{"id":10094,"date":"2018-05-01T14:43:00","date_gmt":"2018-05-01T14:43:00","guid":{"rendered":"http:\/\/euretina.net\/?post_type=resource&p=10094"},"modified":"2022-10-03T14:32:19","modified_gmt":"2022-10-03T14:32:19","slug":"2018-update-on-intravitreal-injections-euretina-expert-consensus-recommendations","status":"publish","type":"resource","link":"https:\/\/euretina.org\/resource\/2018-update-on-intravitreal-injections-euretina-expert-consensus-recommendations\/","title":{"rendered":"2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations"},"content":{"rendered":"\n
Intravitreal injections (IVI) have become the most common intraocular procedure worldwide with increasing numbers every year. The article presents the most up-to-date review on IVI epidemiology and techniques. Unfortunately, important issues related to pre-, peri- and postinjection management lack randomized clinical trials for a final conclusion. Also, a great diversity of approaches exists worldwide. Therefore, expert consensus recommendations on IVI techniques are provided.<\/p>\n